TLSA Stock Analysis: Buy, Sell, or Hold?
TLSA - Tiziana Life Sciences Ltd. Common Shares
$1.51
-0.09 (-5.63%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Get Alerted When TLSA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called TLSA this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TLSA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: TLSA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: TLSA is currently trading at $1.51, which is considered fair relative to its 30-day fair value range of $1.45 to $1.64.
Technical Outlook: Technically, TLSA is in a downtrend. Immediate support is located at $1.36, while resistance sits at $1.77. Short-term momentum is weak, with the stock down 5.6% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.21 (+413.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TLSA is in a downtrend. Immediate support is located at $1.36, while resistance sits at $1.77. Short-term momentum is weak, with the stock down 5.6% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.21 (+413.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$1.45 -
$1.64
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.5%
Protect Your Profits
Holding TLSA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.6%)
- BULLISH: Trading 413.0% below Wall St target ($8.21)
- CAUTION: Recommendation downgraded due to -7.4% 5-day decline
Fair Price Analysis
30-Day Fair Range
$1.45 -
$1.64
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$1.36
Resistance Level
$1.77
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-10.81
Wall Street Target
$8.21
(+413.0%)
Last updated: January 31, 2026 11:07 AM ET
Data refreshes hourly during market hours. Next update: 12:07 PM
Data refreshes hourly during market hours. Next update: 12:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TLSA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$210 | 57 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 62 BUY |
|
ARVN
Arvinas Inc |
BUY
21 analysts |
$13 | 63 BUY |
Advanced TLSA Option Strategies
Professional options setups generated by AI based on today's TLSA price and gamma walls.
